Cargando…

Incremental prognostic value of cardiac metaiodobenzylguanidine imaging over the co‐morbid burden in acute decompensated heart failure

AIMS: Co‐morbidities are associated with poor clinical outcomes in patients with chronic heart failure, while cardiac iodine‐123 (I‐123) metaiodobenzylguanidine (MIBG) imaging provides prognostic information in such patients. We sought to prospectively investigate the incremental prognostic value of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kayama, Kiyomi, Yamada, Takahisa, Tamaki, Shunsuke, Watanabe, Tetsuya, Morita, Takashi, Furukawa, Yoshio, Kawasaki, Masato, Kikuchi, Atsushi, Kawai, Tsutomu, Seo, Masahiro, Nakamura, Jun, Kawahira, Masatsugu, Fukunami, Masatake
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Original Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006734/ https://www.ncbi.nlm.nih.gov/pubmed/33438366 http://dx.doi.org/10.1002/ehf2.13173

Ejemplares similares

Prognostic Value of Calculated Plasma Volume Status in Patients Admitted for Acute Decompensated Heart Failure　― A Prospective Comparative Study With Other Indices of Plasma Volume ―
por: Tamaki, Shunsuke, et al.
Publicado: (2019)

Risk stratification of patients with chronic heart failure using cardiac iodine‐123 metaiodobenzylguanidine imaging: incremental prognostic value over right ventricular ejection fraction
por: Tamaki, Shunsuke, et al.
Publicado: (2015)

Prognostic value of impaired hepato‐renal function and liver fibrosis in patients admitted for acute heart failure
por: Kawahira, Masatsugu, et al.
Publicado: (2021)

Impact of adjunctive tolvaptan on sympathetic activity in acute heart failure with preserved ejection fraction
por: Tamaki, Shunsuke, et al.
Publicado: (2020)

Extraction of a “floating leadless pacemaker”: A case report
por: Kawasaki, Masato, et al.
Publicado: (2020)

Prognostic Significance of Serum Cholinesterase Level in Patients With Acute Decompensated Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT‐HFpEF Registry
por: Seo, Masahiro, et al.
Publicado: (2019)

Clinical Determinants of Quality of Life in Patients With Acute Decompensated Heart Failure With Preserved Ejection Fraction: Insights From the PURSUIT-Heart Failure With Preserved Ejection Fraction Registry
por: Seo, Masahiro, et al.
Publicado: (2022)

Transcatheter Mitral Valve Edge-to-Edge Repair for Commissure Prolapse Successfully Guided by Stitch Artifact Technique
por: Seo, Masahiro, et al.
Publicado: (2022)

Clinical impact of estimated plasma volume status and its additive effect with the GRACE risk score on in-hospital and long-term mortality for acute myocardial infarction
por: Kawai, Tsutomu, et al.
Publicado: (2021)

Prognostic significance of serum chloride level in heart failure patients with preserved ejection fraction
por: Seo, Masahiro, et al.
Publicado: (2022)

The clinical relevance of quality of life in heart failure patients with preserved ejection fraction
por: Seo, Masahiro, et al.
Publicado: (2022)

Complete remission of metastatic pheochromocytoma in (123)I-metaiodobenzylguanidine scintigraphy after a single session of (131)I-metaiodobenzylguanidine therapy: a case report
por: Sugino, Teruaki, et al.
Publicado: (2017)

Incremental Prognostic Value of Conventional Echocardiography in Patients with Acutely Decompensated Heart Failure
por: Soares, Fabio Luis de Jesus, et al.
Publicado: (2017)

Prognostic Importance of Pulmonary Arterial Capacitance in Acute Decompensated Heart Failure With Preserved Ejection Fraction
por: Nakagawa, Akito, et al.
Publicado: (2021)

Delirium is associated with high mortality in older adult patients with acute decompensated heart failure
por: Pak, Misun, et al.
Publicado: (2020)

Use of carperitide infusion for acutely decompensated heart failure
por: Morita, Yoshihisa, et al.
Publicado: (2012)

Prognostic relevance of elevated plasma osmolality on admission in acute decompensated heart failure with preserved ejection fraction: insights from PURSUIT-HFpEF registry
por: Nakagawa, Akito, et al.
Publicado: (2021)

Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin
por: WANG, STEPHANIE S., et al.
Publicado: (2014)

(123)I‐Metaiodobenzylguanidine Myocardial Scintigraphy in Discriminating Degenerative Parkinsonisms
por: Catalan, Mauro, et al.
Publicado: (2021)

Two Cases of Decreased (123)I-Metaiodobenzylguanidine Lung Uptake in Metaiodobenzylguanidine Scintigraphy While Taking Selective Serotonin Reuptake Inhibitor/Serotonin Noradrenaline Reuptake Inhibitor
por: Adaniya, Shinobu, et al.
Publicado: (2021)

Autonomic disorders and myocardial 123I-metaiodobenzylguanidine scintigraphy in Huntington’s disease
por: Assante, Roberta, et al.
Publicado: (2020)

Effectiveness of systemic thrombolysis on clinical outcomes in high-risk pulmonary embolism patients with venoarterial extracorporeal membrane oxygenation: a nationwide inpatient database study
por: Nishimoto, Yuji, et al.
Publicado: (2023)

Trends in Treatment Patterns and Outcomes of Patients With Pulmonary Embolism in Japan, 2010 to 2020: A Nationwide Inpatient Database Study
por: Nishimoto, Yuji, et al.
Publicado: (2023)

Prognostic value of cardiac (123)I‐metaiodobenzylguanidine imaging for predicting cardiac events after transcatheter aortic valve replacement
por: Kadoya, Yoshito, et al.
Publicado: (2021)

A prediction model for 5-year cardiac mortality in patients with chronic heart failure using (123)I-metaiodobenzylguanidine imaging
por: Nakajima, Kenichi, et al.
Publicado: (2014)

Assessment of the efficacy and toxicity of (131)I-metaiodobenzylguanidine therapy for metastatic neuroendocrine tumours
por: Nwosu, A C, et al.
Publicado: (2008)

I -123 metaiodobenzylguanidine imaging for predicting ventricular arrhythmia in heart failure patients
por: Zhou, Weihua, et al.
Publicado: (2013)

The role of (131)I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma
por: Schoot, Reineke A., et al.
Publicado: (2013)

Iodine-131 Metaiodobenzylguanidine Therapy for Neuroblastoma: Reports So Far and Future Perspective
por: Kayano, Daiki, et al.
Publicado: (2015)

Thyroid function after diagnostic (123)I-metaiodobenzylguanidine in children with neuroblastic tumors
por: Clement, Sarah C., et al.
Publicado: (2022)

Combination of Neutrophil‐to‐Lymphocyte and Platelet‐to‐Lymphocyte Ratios as a Novel Predictor of Cardiac Death in Patients With Acute Decompensated Heart Failure With Preserved Left Ventricular Ejection Fraction: A Multicenter Study
por: Tamaki, Shunsuke, et al.
Publicado: (2022)

Influence of renal dysfunction on inhospital morbidity and mortality of patients with decompensated heart failure
por: Rocha, RM, et al.
Publicado: (2005)

(123)I-Labelled metaiodobenzylguanidine for the evaluation of cardiac sympathetic denervation in early stage amyloidosis
por: Noordzij, Walter, et al.
Publicado: (2012)

Uptake Index of (123)I-metaiodobenzylguanidine Myocardial Scintigraphy for Diagnosing Lewy Body Disease
por: Kamiya, Yoshito, et al.
Publicado: (2017)

Designing and Comparing Performances of Image Processing Pipeline for Enhancement of I-131-metaiodobenzylguanidine Images
por: Pandey, Anil Kumar, et al.
Publicado: (2021)

The efficacy and safety of Iodine-131-metaiodobenzylguanidine therapy in patients with neuroblastoma: a meta-analysis
por: He, Huihui, et al.
Publicado: (2022)

Cardiac 123I-Metaiodobenzylguanidine (MIBG) Scintigraphy in Parkinson’s Disease: A Comprehensive Review
por: Pitton Rissardo, Jamir, et al.
Publicado: (2023)

Late gadolinium enhancement on cardiac magnetic resonance combined with (123)I- metaiodobenzylguanidine scintigraphy strongly predicts long-term clinical outcome in patients with dilated cardiomyopathy
por: Chimura, Misato, et al.
Publicado: (2019)

The Patency of Tibial/Peroneal Arteries Affects the Increment of Regional Tissue Saturation of Oxygen in Each Angiosome after Superficial Femoral Artery Revascularization
por: Unno, Naoki, et al.
Publicado: (2022)

Correction of collimator-dependent differences in the heart-to-mediastinum ratio in (123)I-metaiodobenzylguanidine cardiac sympathetic imaging: Determination of conversion equations using point-source imaging
por: Inoue, Yusuke, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lhald43pb1srn9m4p089o0d7ko